(UroToday.com) Dr. Cyrill Rentsch, University Hospital Basel Department of Urology, Switzerland presented “Results of a Phase I/II Single-Arm Clinical Trial Assessing Efficacy, Safety and Tolerability of the Recombinant Bacillus Calmette Guérin VPM1002BC in Patients with Non-Muscle-Invasive Bladder Cancer Recurrence after BCG Induction With or Without BCG Maintenance Therapy – SAKK 06/14.”